Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
May 2, 2021 • 3min
CGRP Inhibitor Use for Migraine and Exacerbation of Raynaud Phenomenon
Dr. Ilana Breen discusses her abstract, "Calcitonin Gene-Related Peptide Inhibitor Use for Migraine Associated with Exacerbation of Raynaud Phenomenon". You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
May 1, 2021 • 4min
Safety and Efficacy of the Telestroke Drip-and-Stay Model
Dr. Hena Waseem discusses her abstract, "Safety and Efficacy of the Telestroke Drip-and-Stay Model: A systematic review and meta-analysis". You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
Apr 30, 2021 • 3min
Medical Research Funding
In part 2 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about funding for medical research in the U.S.
Apr 29, 2021 • 3min
Veterans Affairs Centers of Excellence
In part 1 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about the Veterans Affairs Centers of Excellence.
Apr 28, 2021 • 2min
Johnson & Johnson COVID-19 Vaccination
Dr. Peter Marks discusses the Johnson & Johnson COVID-19 vaccine.
Apr 27, 2021 • 1min
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Professor Maria Eriksdotter discusses whether Cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk.
Apr 26, 2021 • 3min
Early Recognition of CNS complications During Treatment of MS
Dr. Martijn Wijburg discusses pharmacovigilance of patients treated with disease-modifying therapies for MS. Show references: https://pubmed.ncbi.nlm.nih.gov/33229453/
Apr 25, 2021 • 3min
Long-Term Survival of Participants in the CENTAUR Trial for ALS
Dr. Sabrina Paganoni discusses her abstract, "Long-Term Survival of Participants in the CENTAUR Trial of AMX0035 for ALS". You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
Apr 24, 2021 • 4min
Oral Rimegepant in Adults With Migraine and Cardiovascular Risk Factors
Dr. Susan Hutchinson discusses her abstract, "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study". You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
Apr 23, 2021 • 3min
Gender and Racial/Ethnic Diversity amongst Neurology Residents and Physicians
Dr. Fabiola Valenzuela discusses her abstract, "An Assessment of Gender and Racial/Ethnic Diversity amongst Neurology Residents and Physicians". You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
